Imam, M. H., Sinakos, E., Gossard, A. A., Kowdley, K. V., Luketic, V. A. C., Harrison, M. E., . . . Lindor, K. D. (2011). High dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis.
シカゴスタイル引用形Imam, Mohamad H., et al. High Dose Ursodeoxycholic Acid Increases Risk of Adverse Outcomes in Patients With Early Stage Primary Sclerosing Cholangitis. 2011.
MLA引用形式Imam, Mohamad H., et al. High Dose Ursodeoxycholic Acid Increases Risk of Adverse Outcomes in Patients With Early Stage Primary Sclerosing Cholangitis. 2011.
警告: この引用は必ずしも正確ではありません.